Optimized Ruthenium-Catalyzed Synthesis of a Key Rimegepant Intermediate

Achieving high yield, purity, and enantioselectivity in pharmaceutical intermediate production.

Get a Quote & Sample

Advantages Offered

Enhanced Enantioselectivity

Our optimized process for Rimegepant intermediate production guarantees superior enantioselectivity, a crucial factor for the efficacy of the final drug.

Manufacturing Scale-Up

We excel in the scalable synthesis of Rimegepant intermediate, ensuring reliable supply for large-scale pharmaceutical manufacturing.

Process Cost Efficiency

The adopted Ruthenium-catalyzed ATH reaction for Rimegepant intermediate is designed for cost-effective Rimegepant intermediate synthesis, offering economic advantages.

Key Applications

Migraine Treatment Drug Synthesis

This intermediate is a cornerstone in the manufacturing of Rimegepant, a novel treatment for migraines.

CGRP Antagonist Development

Essential for producing calcitonin gene-related peptide antagonists, targeting a key pathway in pain management.

Advanced Pharmaceutical Research

Supports ongoing research and development in new therapeutic areas by providing a high-quality building block.

Custom Chemical Synthesis

Serves as a foundational compound for various custom chemical synthesis projects requiring precise stereochemistry.

Why Choose Us?

Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.

Global Experience

With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.

Advanced Facilities

Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.

Seamless Scalability

We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).